This study aimed to investigated the prevalence and resistance pattern of different Citrobacter species phenotypically and genotypically to β-lactam and some most common antibiotics then evaluate the antibacterial activity of omega-3 extracted from flaxseed against isolates that harboring resistance genes. 19 Citrobacter isolates were isolated from100 stool and urine samples taken from patients attended to AL-Sadar Hospital during June-December 2016. Clinical samples were cultured on specific media, thereafter isolates were identified depending on morphological, biochemical characteristics and VITK-2. The results showed that the Citrobacter comprise 24% of isolated bacteria which divided into 11 (14.1%) were C. freundii, 5 (6.41%) C. kosaeri and C. farmeri were 3 (3.8%). The antagonistic activity was evaluated by observing a clear zone of inhibition growth, the results showed that all Citrobacter (100%) isolates were resistant to Ampicillin, cefoxitin and sensitive to Imipinim, also the isolates showed different degrees of resistant to β-lactam antibiotics initially. By confirmatory test the results observed 17/19 (89.4%) isolated were ESBL producers finally using PCR technique to detect bla–genes (blaCTX-M, OXA, SHV and Z). The results revealed that 14/17 (82.3) of potential ESBL producing Citrobacter were harbor one or more of ESBL genes they included 10 of C. freundii and 4 of C. koseri. The extraction of essential fatty acid semicarbazide (omega-3) from Linum usitatissium (Flax seed) were tested to evaluate their activity against resistant isolates, results explained broad spectrum antibacterial property of EFASC compounds against resistant bacteria. In conclusion, this study found increase prevalence of MDR Citrobacter spp as causative agents in clinical cases. Considering antibacterial activity of EFASC, it was observed highly activity against resistant pathogens deservedly, therefore attention must be paid to development their used as alternative antibiotics.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Ahmad A. A., Darweesh M. A. & Ahmad A. M. 2017. The Antibacterial of Essential Fatty Acid Semicarbazide Extracted from Flaxseed Oil Against Some Nosocomial Infection Bacteria in Iraq. IJCPR; 8(1) January-February: 31-39.
Al-Hasnawi A. A. 2014. Comparison of biochemical tests, Api system, Vitek 2 system and PCR of the enteropathogenic bacteria isolated from children with persistent diarrhea. And the occurrence of virulence factors and antibiotic resistance in the isolates.Master Thesis. Faculty of Science, University of Kufa.
Al-Hissnawy D., Al-Thahab A. & Al-Jubori S. 2012. Evaluation of Citrobacter freundii isolated in Najaf governorate as an enterotoxin producer. Medical J. of Babylon. 9(1): 1-5.
Al-Muhannak F. H. N. 2010. Spread of Some Extended Spectrum Beta-Lactamases in Clinical Isolates of Gram Negative Bacilli in Najaf. M.Sc. Thesis. College of Medicine, University of Kufa.
Al-Muslemawi Th. A. 2007. Study of some biochemical, biological and pathological properties of lipopolysaccharide extracted from Citrobacter freundii. Ph.D. Thesis. Baghdad univ.
Batchoun R. G., Swedan S. F. & Shurman A. M. 2009. Extended spectrum β-lactamases among Gram-negative bacterial isolates from clinical specimens in three major hospitals in Northern Jordan. J. Micro. Res. Article, ID 513874.
Borhade S. 2014. Synthesis, Characterisation and Antimicrobial Activity of Essential Fatty Acid of Semicarbazide. Int. J. of Chem. Scie. and Applic. 5(2): 46-55.
Bush K., Jacoby G. & Medeiros A. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Anti. Agents Chemo. 39: 1211-1233.
CLSI 2014. Performance Standards for Antimicrobial Susceptibility Testing: Twenty – Fourth Informational Supplement M02-A11, M 0-A11, and M11-A8. Wayne, PA, USA.
Colom K., Perez J., Alonso R., Fernandez-Aranguiz A., Eva Larino E. & Cisterna R. 2003. Simple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiology Letters, 223: 147-151.
Dancer S. J. 2001. The problem of Cephalosporin. J. of Antimic. Chemo. 48: 463-478.
Desbois A. P. & Lawlor K. C. 2013. Antibacterial Activity of Long-Chain Polyunsaturated Fatty Acids against Propionibacterium acnes and Staphylococcus aureus. Mar. Drugs 11: 4544-4557.
Egharevba H. O., Kunle O. F., Iliya I., Orji P. N., Abdullahi M. S., Okwute S. K. & Okogun J. I. 2010. Phytochemical analysis and antimicrobial activity of Punica granatum L. (fruit and leaves). New York Scie. J. 3(12): 91-98.
Erlandsson M. 2007. Surveillance of antibiotic consumption and antibiotic resistance in Swedish intensive care units. Linkoping University Medical Dissertations No. 1019 Sweden.
Fuad M. M. H., Ferdowsy H., Hossain M. N., Foysal M. J. & Rahman M. M. 2012. In Vitro Antibacterial Activity of Common Antibiotics and Herb Extracts to Clinical Isolates of Escherichia coli Collected from UTI Patient. Int. J. of Rese in Pharmacel and Biomedi Sciences. 3(2): 987-992.
Harborne J. B. 1984. Phytochemical Methods.; A Guide to Modern Techniques of Plant Analysis, 2nd ed. Chapman and Hall, London
Harvey R. A. & Champe D. C. 2012. Lippincott’s Illustrated Reviews: Pharmacology 5th ed., Lippincott Williams and Wilkins, USA. 382-385.
Hassan M. M., Gaber A., Attia O. A. & Ayman R. B. 2014. Molecular characterization of antibiotic resistance genes in pathogenic bacteria isolated from Patients in Taif Hospitals, KSA. AJPCT. 2(8): 939-951.
Hassan M., Alkharsah K. R., Alzahrani A. J., Obeid O. E., Khamis A. H. & Diab A. 2013. Detection of extended spectrum beta-lactamases-producing isolates and effect of AmpC overlapping. Infect. Dev., 7(8): 618-629.
Huang Z. M., Mao P. H., Chen, Y.; Wu, L. and Wu, J. (2004). Study on molecular epidemiology of SHV type beta-lactamase encoding genes of multiple-drug - resistant Acinetobacter baumannii. Zhonghua Liu Xing Bing Xue Za Zhi.,25: 425-427.
Ibarguren M., Lopez D. & Escriba P. 2014. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochi. et Bioph. Acta. 1838: 1518-1528.
Janda J. M., Abbott S. L., Cheung W. K. & Hanson D. F. 1994. Biochemical identification of citrobacteria in the clinical laboratory. J of Clini Microbi. 32(8): 1850-1854.
MacFaddin J. E. 2000. Individual Biochemical Tests For Identification of Medical Bacteria. 3th ed. Lippincott Williams Wilkins, London: 57-424.
Metri B. C., Jyothi, V. X. & Peerapur B. V. 2013. Antibiotic resistance in Citrobacter spp. isolated from urinary tract infection. Urol Ann. Oct-Dec; 5(4): 312-315.
Mogensen T. H. 2009. Pathogen recognition and inflammatory Signaling in innate immune. Defenses. Clin. Micro. Rev. 22(2): 240-273.
Nada T., Baba H., Kawamura K., Ohkura T., Torii K. & Ohta M. A. 2004. Small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward. JPN. Journal of Infectious Diseases. 57: 181-182.
Pandya P., Harisha C. R., Shandla V. J. & Chandola H. M. 2013. Pharmoacogostical and Photochemical evaluation Atasi (Linum ustatissimmum L.). Indian Journal of Tradition Knowledge. 12(4): 688-692.
Perilli M., Mugnaioli C., Luzzaro F., Fiore M., Stefani S., Rossolini G. & Amicosante G. 2005. Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate. Antimicrob. Agents Chemother. 49: 1564-1566.
Salih M. K., Alrabadi N. I., Thalij K. M. & Hussien A. S. 2016. Isolation of Pathogenic Gram-Negative Bacteria from Urinary Tract Infected Patients. Open Journal of Medical Microbiology, 6: 59-65.
Sami H., Sultan A., Rizvi M., Khan F., Ahmad Sh., Shukla I. & Khan H. 2017. Citrobacter as a uropathogen, its prevalence and antibiotics susceptibility pattern. 4(1): 23-26.
Seidel V. & Taylor P. W. 2004. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria. Int. J. Antimicrob. Agents, 23: 613-619.
Shahid M. 2010. Citrobacter spp. Simultaneously harboring bla-CTX-M, blaTEM, blaSHV, bla-ampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance. J of Clin. Microbi. 48(5): 1833-1838.
Shih C.-C., Chen C., Chang S.-C., Luh K.-T. & Hsieh W.-C. 1996. Bacteremia due to Citrobacter species: significance of primary intraabdominal infection. Clinical Infectious Diseases. 23(3): 543-549.
Shin S. Y., Bajpai H. R. & Kang S. C. 2007. Antibacterial activity of ecosapantaenoic acid (EPA) against foodborne and food spoilage microorganism. LWT – Food Sci. Tech., 40: 1515-1519.
Singhal M. & Paul A. 2011. Antibacterial evaluation of synthesized methyl semicarbazone derivatives. IJPSR. 2(10): 2602-2604.
Stewart Z. E., Shaker M. & Baxter J. D. 2017. Inflammation and Infection Urinary Tract Infection Caused by Citrobacter koseri in a Patient With Spina Bifida, an Ileal Conduit and Renal Caluli Progressing to Peri-nephric Abscess and Empyema. Urology Case Reports 11: 22-24.
Svärd L. 2007. Evaluation of phenotypic and genotypic extended spectrum beta-lactamase detection method. M.Sc. Thesis. School of Biological Sciences, Dublin Institute of Technology, Uppsala University, Germany.
Tuwaij N. S. 2016. Molecular Study of Quinolone Resistance in Klebsiella pneumoniae and Citrobacter freundii Isolates. Al-Kufa University J. for Biology 8(3): 300-312.
Wang H., Wang J., Qiu C., Ye Y., Guo X., Chen G., Li T., Wang, Y., Fu X. & Liu R. 2017: Comparison of phytochemical profiles and health benefits in fiber and oil flaxseeds (Linum usitatissimum L.). Food Chem. Jan 1; 214: 227-233.
Warren J., Farmer J., Dewhirst F., Birkhed K. & Zembower T. 2000. Out break of nosocomial infection due to extended – spectrum beta-lactamase producing strain of enteric group 137, a new member of the family Enterobacteriaceae closely related to citrobacter farmer and C. amalonatica. J. Clin. Microbio. 38(11): 3946-52.